Alliar Announces 1Q17 Results

USA - English

• Brazil - Português

BELO HORIZONTE, Brazil, May 10, 2017 /PRNewswire/ -- Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (BM&FBOVESPA: AALR3), announces today its results for the first quarter of 2017 (1Q17).

Highlights:

• Net Revenue growth of 32% with 13% coming from same stores sales (SSS);
• Acquisition of Multiscan (leader in diagnostic imaging in the Espirito Santo state);
• Addition of 4 mega stores and 11 collection points; closure of 4 standard units;
• Magnetic Resonance (MRI): 6 new MRI's machines; 28% growth in number of exams, 22% increase in daily average occupation (22.6 exams per machine);
• Clinical Analysis (CA): 80 new clinical analysis rooms; 26% growth in number of exams, 11% average ticket increase;
• Adjusted EBITDA of R$ 49.7 million (R$ 51.3 million considering Multiscan since Jan 1st), with 20.1% margin
• Recurring operating cash flow of R$ 24.1 million, 29% growth;
• 17.2% ROIC without goodwill, increase of 141 bps;
• Net Promoter Score (NPS) of 70.5%;

For Further Information: ir.alliar.com  

CONTACT

INVESTOR RELATIONS TEAM
Carlos Araujo | IRO
Francisco de Paula| IR Manager
Tel.: +5511 4368-1387
E-mail: [email protected]

SOURCE Alliar

Related Links

http://www.alliar.com